企業プロフィール · Healthcare

China Resources Sanjiu Medical & Pharmaceutical Co Ltd

000999 · 深圳
国 / 地域
China
上場日
1999年11月11日
従業員数
30,304
公式サイト
www.999.com.cn
Buffett Score
80/100
卓越
時価総額元 402.57億
売上高(TTM)元 318.06億
EBITDA元 53.15億
純利益率10.3%
ROE10.3%
PER (TTM)12.28
予想PER16.47
PEG1.38
EPS元 1.97
配当利回り4.29%
52週レンジ元 21.60 – 元 29.90

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese medicine health products; and vitamins, minerals, protein powder, collagen, probiotics, health foods, and formula granules. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. was incorporated in 1999 and is headquartered in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources Pharmaceutical Group Limited.

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。

この銘柄のレポートはお使いの言語でまだありません。